Uterine cancer medical therapy

Uterine cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Differentiating Uterine cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Staging
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Uterine cancer medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Uterine cancer medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Uterine cancer medical therapy
CDC on Uterine cancer medical therapy
Uterine cancer medical therapy in the news
Blogs on Uterine cancer medical therapy
Directions to Hospitals Treating Uterine cancer
Risk calculators and risk factors for Uterine cancer medical therapy

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Chemotherapy

Chemotherapy may be considered in some cases, especially for those with stage 3 and 4 disease. Cisplatin is an inhibitor of DNA synthesis and is preferred.

Hormonal therapy

Hormonal therapy with progestins and antiestrogens has been used for the treatment of endometrial stromal sarcomas.

Contraindicated medications

Endometrial cancer is considered an absolute contraindication to the use of the following medications:

• Drospirenone and Ethinyl estradiol
• Norethindrone acetate and Ethinyl estradiol
• Norgestimate and Ethinyl estradiol
• Norgestrel and Ethinyl estradiol

References

Template:WikiDoc Sources